Mike Nolan has nearly three decades of experience and a proven record of delivering transformative diagnostic technologies to drive better outcomes for patients. Currently, Mike leads a multidisciplinary team of experts committed to radically transforming cancer care with a multiomics platform to detect cancer in its earliest stages using a standard blood draw. He is passionate about health equity and access to care. From overseeing the largest, most diverse clinical study of its kind for colorectal cancer (CRC), to working closely with community and industry leaders to expand access to screening, Mike inspires teams to develop and execute strategies that achieve remarkable results. Mike has also held leadership roles for some of the most recognized names in healthcare and diagnostics.
Track Chair: Cindy Perettie, Roche